Eli Lilly

Explore the latest insights on Eli Lilly and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Eli Lilly’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Explore the latest insights on Eli Lilly and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Eli Lilly's developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Porton Advanced Solutions Partners with Hangzhou Aisijia Biotech on Diabetes Cell Therapy – CDMO to Provide Process Development, GMP Manufacturing and China IND Filing Support for Autologous Pancreatic Progenitor Cell Program
CompanyDeals

Porton Advanced Solutions Partners with Hangzhou Aisijia Biotech on Diabetes Cell Therapy – CDMO to Provide Process Development, GMP Manufacturing and China IND Filing Support for Autologous Pancreatic Progenitor Cell Program

Porton Advanced Solutions Ltd. ("Porton Advanced Solutions") and Hangzhou Aisijia Biotech Co., Ltd. ("Aisijia Biotech") announced a strategic collaboration centered on the new drug clinical trial (IND) application in China…

EMA's CHMP Backs Indication Extension for Johnson & Johnson's TALVEY – Talquetamab Combination Moves Toward Earlier‑Line Relapsed/Refractory Multiple Myeloma

EMA’s CHMP Backs Indication Extension for Johnson & Johnson’s TALVEY – Talquetamab Combination Moves Toward Earlier‑Line Relapsed/Refractory Multiple Myeloma

Ascentage Pharma Signs Strategic Collaboration with Suzhou University and Its First Affiliated Hospital – Tripartite Partnership Targets Hematologic Oncology Innovation

Ascentage Pharma Signs Strategic Collaboration with Suzhou University and Its First Affiliated Hospital – Tripartite Partnership Targets Hematologic Oncology Innovation

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Yirui Pharmaceutical’s YR001 Completes Successful Phase I Clinical Study in the US

CompanyDrug

Eli Lilly’s Omvoh Receives FDA Approval for Ulcerative Colitis Treatment

CompanyDeals

Eli Lilly Acquires Mablink Bioscience to Expand Next-Gen ADC Portfolio

CompanyDrug

Eli Lilly’s Tirzepatide Shows Robust Weight Loss Results in Phase III Study

CompanyDrug

Eli Lilly Launches Three New Oncology Programs Targeting KRAS and Nectin-4

CompanyDrug

FDA Rejects Eli Lilly’s Application for Lebrikizumab in Atopic Dermatitis Treatment

CompanyDrug

Eli Lilly’s Insulin Biosimilar YouBiAn Approved for Diabetes Treatment in China

Drug

United Laboratories Receives FDA Approval for Clinical Study of UBT251 for Obesity Treatment

Show More